End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.06 CNY | -2.38% | -0.12% | +46.46% |
13/05 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
25/04 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+46.46% | 2B | |
+42.64% | 6.38B | |
-15.52% | 4.59B | |
+8.35% | 3.39B | |
-11.10% | 3.2B | |
-4.12% | 2.52B | |
-7.97% | 1.7B | |
-1.07% | 1.65B | |
-11.56% | 1.58B | |
+47.37% | 1.55B |
- Stock Market
- Equities
- 600285 Stock
- News Henan Lingrui Pharmaceutical Co., Ltd.
- Henan Lingrui Pharma Registers Chewable Asthma Drug in China